U-Pump completed MVP and Metrological Test

HOUSTON - March 31, 2025 - PRLog -- Houston,  U-Pump, a medical device startup revolutionizing diabetes care, is proud to announce the completion of its functional MVP and the successful issuance of its Metrological Test Report for the virtual model of its infusion micropump. This achievement marks a major milestone in the company's mission to make intelligent insulin therapy accessible, affordable, and precise for millions worldwide.

U-Pump addresses a critical gap in the $13B insulin pump market by targeting the 80% of insulin-dependent patients who are underserved by traditional pumps due to cost, complexity, or discomfort. Unlike current solutions, U-Pump offers:

• OneMove™ technology for painless, one-step application
• Modular, reusable design reducing cost and medical waste
• Seamless CGM integration (Dexcom, Libre)
• AI-powered dosing for real-time glucose control
• Subscription model with insurance integration

Early traction includes:

• 435 pre-orders, including 131 paid, totaling $14,000
• 2 patents filed, 4 in progress
• LTV: $8,700, CAC: $1,500, 80–90% gross margins
• Projected revenue: $127M (Year 1), $1.4B (Year 4)

The company is now preparing for FDA pre-submission, engaging with the Diabetes community and other research partners for expert validation.

U-Pump is raising $5M via SAFE notes (starting from $200K) to finalize regulatory steps, conduct clinical trials, and scale in the U.S., EU, and Israel.

"Millions are left behind by current insulin pumps. With U-Pump, we're making smart, precise, and affordable therapy a reality," — Alexander Senkevich, CEO.

Contact:
Alexander Senkevich
ceo@u-pump.com

https://www.crunchbase.com/organization/u-pump
https://www.linkedin.com/company/u-pump/